Viela Bio Becomes Latest Biotech Intent on Going Public with $150M Offering

Published on :

Viela Bio Becomes Latest Biotech Intent on Going Public with $150M Offering AstraZeneca spinout files for IPO on Nasdaq August 29, 2019 Viela Bio, the AstraZeneca spin-off biotech, has captured the attention of industry insiders since their $250M Series A investment that launched the company in 2018 and they are continuing to do becoming the [….]